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ABSTRACT
Eukaryotic ribosome biogenesis is a highly orchestrated process involving numerous assembly factors including ATP-de-
pendent RNA helicases. The DEAH helicase DHX37 (Dhr1 in yeast) is activated by the ribosome biogenesis factor
UTP14A to facilitate maturation of the small ribosomal subunit. We report the crystal structure of DHX37 in complex
with single-stranded RNA, revealing a canonical DEAH ATPase/helicase architecture complemented by a structurally
unique carboxy-terminal domain (CTD). Structural comparisons of the nucleotide-free DHX37-RNA complex with DEAH
helicases bound to RNA andATP analogs reveal conformational changes resulting in a register shift in the bound RNA, sug-
gesting a mechanism for ATP-dependent 3′–5′ RNA translocation. We further show that a conserved sequence motif in
UTP14A interacts with and activates DHX37 by stimulating its ATPase activity and enhancing RNA binding. In turn, the
CTD of DHX37 is required, but not sufficient, for interaction with UTP14A in vitro and is essential for ribosome biogenesis
in vivo. Together, these results shed light on themechanism of DHX37 and the function of UTP14A in controlling its recruit-
ment and activity during ribosome biogenesis.
Keywords: RNA helicase; X-ray crystallography; ribosome biogenesis
INTRODUCTION
Composed of four ribosomal RNAs (rRNAs) and ∼80 pro-
teins, eukaryotic ribosomes are complex ribonucleopro-
tein (RNP) nanomachines whose biogenesis is a highly
orchestrated and regulated process (Kressler et al. 2017;
Peña et al. 2017). Ribosome assembly starts in the nucleo-
lus with the transcription of a large precursor, known as the
47S preribosomal RNA (pre-rRNA) in mammalian cells,
containing the future 18S, 5.8S and 28S rRNAs interspaced
internally with noncoding internal transcribed spacers
(ITS1 and ITS2) and flanked by 5′ and 3′ external tran-
scribed spacers (5′ and 3′ ETS). The pre-rRNA transcript
undergoes extensive processing and modification concur-
rently with RNA folding and ribosomal protein recruitment
(Henras et al. 2015). An early cleavage event within ITS1
separates the 18S rRNA and 5.8S-28S rRNA fragments,
leading to independent assembly pathways of the 40S
and 60S subunits, which are eventually exported to the cy-
toplasm for their final maturation. Eukaryotic ribosome
biogenesis is dependent on ∼75 small nucleolar RNAs
(snoRNAs) that guide rRNA folding and site-specific mod-
ifications, and more than 200 protein assembly factors, in-
cluding exo- and endonucleases, ATPases, GTPases, and
DExH/D-box RNA helicases (Woolford and Baserga
2013). U3 small nucleolar RNA (snoRNA) is a key compo-
nent of the small subunit (SSU) processome, an early stable
intermediate of 40S subunit assembly (Phipps et al. 2010).
By hybridizing to the 5′-ETS and regions of the pre-18S
rRNA, U3 facilitates initial folding of the pre-rRNA and for-
mation of individual 18S rRNA domains, and is required for
nucleolytic cleavage within the 5′ ETS and ITS1 (Beltrame
and Tollervey 1992).
DExH/D-box ATPases belonging to the SF2 helicase
superfamily use their ATP-dependent RNA binding or
translocation activities to catalyze structural remodeling
of RNAs or RNP complexes (Jankowsky and Fairman
2007; Fairman-Williams et al. 2010; Jankowsky 2011;
Jarmoskaite and Russell 2014). Whereas DEAD-box heli-
cases unwind RNA secondary structures by binding to
anddistorting RNAduplexes in anATP-dependentmanner
(Yang et al. 2007; Hilbert et al. 2009), DEAH/RHA helicases
(also termed DExH or DEAH helicases, and referred to as
DEAH helicases herein) generally unwind RNA duplexes
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or remodel RNPs by processive, ATP-driven translocation
along an RNA strand in the 3′–5′ direction (Büttner et al.
2007; Pyle 2008; He et al. 2010; Walbott et al. 2010;
Linder and Jankowsky 2011). DExH/D-box helicases com-
prise a coremodule built of two RecA-like domains that uti-
lize conserved sequence and structural motifs to bind ATP
(motifs I, II, III, Va, and VI) and RNA (motifs Ia, Ib, Ic, IV, IVa,
and V) (Jankowsky and Fairman 2007). Most DExH/D-box
helicases do not possess intrinsic substrate specificity since
RNA binding occurs via the ribose-phosphate backbone
(Sengoku et al. 2006; Jankowsky 2011; Ozgur et al.
2015). Instead, they rely on protein cofactors for recruit-
ment to specific RNAs and catalytic activation (Sloan and
Bohnsack 2018). The specificity and catalytic activity of
DEAH helicases is typically regulated by interactions with
G-patch proteins (Robert-Paganin et al. 2015).
In yeast, 17 DExH/D-box RNA helicases are essential for
ribosome biogenesis as they promote snoRNA removal
and effect structural rearrangements in the assembling ri-
bosomal subunits (Martin et al. 2014). The DEAH helicase
Dhr1 is required for the assembly of the 40S subunit
(Colley et al. 2000; Granneman et al. 2006). Using its heli-
case activity, Dhr1 displaces U3 snoRNA from the 5′-termi-
nal part of the pre-18S rRNA, thereby promoting the
formation of the central pseudoknot, a critical step in the
folding of the 18S rRNA (Sardana et al. 2015). Dhr1 is sup-
ported by the ribosomal biogenesis factor Utp14 and the
rRNA methyltransferase-coactivator complex Bud23–
Trm112, both of which physically interact with the helicase
and facilitate its efficient association with the preribosomal
particle (Sardana et al. 2014; Zhu et al. 2016). Previous
studies have suggested that Utp14, a stable component
of the SSU processome, activates the RNA unwinding ac-
tivity of Dhr1 in vitro and is required for the association
of Dhr1 with the preribosome in vivo (Zhu et al. 2016).
This suggests that Utp14 regulates the recruitment and ac-
tivity of Dhr1 during the transition from the SSU proces-
some to the pre-40S particle, and thereby the timing of
the maturation of the 40S subunit. Dhr1 and Utp14 have
highly conserved mammalian orthologs, DHX37 and
UTP14A, both of which have also been implicated in ribo-
some biogenesis (Choudhury et al. 2018). However, the
structural and mechanistic details of the RNA remodeling
activity of Dhr1/DHX37 and its stimulation by Utp14/
UTP14A remain elusive at present.
To obtain insights into the molecular mechanism of
DHX37/Dhr1 helicases in ribosome biogenesis, we deter-
mined the crystal structure of murine DHX37 in complex
with single-stranded RNA in the absence of adenosine nu-
cleotide, which reveals a conformational state likely corre-
sponding to a nucleotide exchange intermediate and
suggests amechanism forATP-dependent 3′–5′ RNA trans-
location. We further demonstrate that UTP14A stimulates
both the ATPase and RNA binding activities of DHX37,
thereby enhancing the processivity of the helicase.
Finally, we show that a structurally unique carboxy-terminal
domain (CTD) of DHX37, absent from other DEAH heli-
cases, is required for the interaction with UTP14A in vitro
and the function of DHX37 in vivo. Combined, these in-
sights shed light on the role ofUTP14A in controlling the re-
cruitment and activation of DHX37 during 40S subunit
maturation.
RESULTS AND DISCUSSION
Structure of DHX37 bound to ssRNA in the absence
of adenosine nucleotide
DHX37 is a∼130 kDamultidomain protein containing a ca-
nonical DEAH ATPase/helicase catalytic module that com-
prises two RecA-like (RecA1 and RecA2) domains and a
helicase-associated domain (HA2), followed by an oligonu-
cleotide/oligosaccharide-binding fold (OB) domain (Fig.
1A; Ozgur et al. 2015). The RecA1 domain is preceded
by an extended region predicted to lack tertiary structure.
Aiming to obtain structural insights into the molecular
mechanism of DHX37, we expressed an amino-terminally
truncated variant of murine DHX37 (MmDHX37) compris-
ing amino acid residues 179–1150 (MmDHX37179–1150).
The RNA-dependent ATPase activity of MmDHX37179–1150
was indistinguishable from that of full-length MmDHX37,
indicating that the amino-terminal region of DHX37 is
not required for catalytic activity (Supplemental Fig. S1A;
Supplemental Table S1). Fluorescence-polarization assays
were used to monitor RNA binding, revealing that
MmDHX37179–1150 exhibited highest affinity for oligouri-
dine RNA (Supplemental Fig. S1B). RNA binding was re-
duced in the presence of ADP or the nonhydrolyzable
ATP analog AMPPNP (Supplemental Fig. S1C), indicating
that DHX37 does not require adenosine nucleotides
(ADP or ATP) for ssRNA binding and suggesting that
RNA binding is weakened in the ATP- or ADP-bound
states, as observed for other processive SF2 helicases
(Levin et al. 2003; Robert-Paganin et al. 2016). This was
corroborated by a pull-down experiment utilizing biotin-
coupled oligouridine RNA (Supplemental Fig. S1D), which
confirmed that stable ssRNA binding is independent of
adenosine nucleotides.
MmDHX37179–1150 was subsequently crystallized in
complex with uridine decanucleotide (U10), and its struc-
ture determined by single-wavelength anomalous X-ray
diffraction experiment. The structure was refined at a reso-
lution of 2.9 Å to an Rwork of 26.8% and Rfree of 29.7%. The
structure reveals a canonical DEAH ATPase/helicase archi-
tecture (Fig. 1B), in which the RecA-like, HA2, and OB-fold
domains form a compact core, as previously observed in
the structures of the related DEAH/RHA helicases Prp43
(He et al. 2017; Tauchert et al. 2017), MLE (Prabu et al.
2015), DHX36 (Chen et al. 2018b,c), and Prp2 (Schmitt
et al. 2018). An additional α-helical carboxy-terminal
Boneberg et al.
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domain (CTD, Fig. 1A), a distinct feature of DHX37 ortho-
logs, projects away from the helicase core (Fig. 1B). The
CTD has a unique fold not observed in other proteins
and makes few contacts with the helicase core, its orienta-
tion being maintained by crystal contacts with a second
DHX37 molecule in the asymmetric unit of the crystal. In
solution, the CTD is thus likely to be flexibly tethered to
the helicase core and conformationally dynamic.
Although the MmDHX37179–1150-U10 complex was crys-
tallized in the presence of the nonhydrolyzable ATP analog
AMPPNP, no corresponding electron density could be ob-
served in the ATPase active site located at the interface of
the RecA1 and RecA2 domains. Structural comparison of
the DHX37-U10 complex with that of
Chaetomium thermophilum Prp43
bound to U7 RNA and the transition
state analog ADP.BeF3
− (Tauchert
et al. 2017) reveals that the DHX37
ATPase active site has an open confor-
mation in which conserved active site
motifs involved in ATP andMg2+ coor-
dination (Supplemental Fig. S3) adopt
conformations incompatible with
high-affinity ATP binding (Supple-
mental Fig. S4). In particular, superpo-
sition of the RecA1 domains of the
DHX37 and Prp43 complexes shows
that active site motifs Va and VI in the
DHX37 RecA2 domain are displaced
by ∼7 Å away from the position that
they assume in theATP-bound confor-
mation in Prp43 (Supplemental Fig.
S4C) and otherDEAHhelicases (Prabu
et al. 2015; He et al. 2017; Tauchert
et al. 2017; Schmitt et al. 2018).
The U10 RNA is bound predomi-
nantly by sequence nonspecific ionic
and hydrogen-bonding interactions
with the ribose-phosphate backbone
(Supplemental Fig. S2B), as observed
for other DEAH helicases (Prabu et al.
2015; He et al. 2017; Tauchert et al.
2017; Chen et al. 2018b,c). DHX37
makes base-directed interactions
only with nucleotides U1, U5 and U9
(Supplemental Fig. S5), which may
contribute to the observed binding
preference of DHX37 for uridine-rich
RNA (Supplemental Fig. S1B). The
5′-terminal part of the RNA binds in
a surface cleft along the OB domain,
with phosphate groups of nucleotides
U3 and U4 contacted by two threo-
nine residues in the β20–β21 loop in
the OB domain and by His960 in the
β18–β19 loop (Fig. 1C). In turn, nucleotides U5–U10 are
bound in a central channel within the helicase core, sur-
rounded by the RecA1, RecA2, HA2, and OB domains.
Throughout the channel, the RNA is stabilized by ionic in-
teractions with the basic side chain groups of phylogenet-
ically conserved amino acid residues Lys635 (RecA2
domain), Arg803 (HA2), Arg303, Arg304, and Arg330 (all
RecA1). At the 5′-proximal end of the RNA-binding chan-
nel, the RNA backbone passes through a narrow opening
formed by the HA2 and OB domains and a long β-hairpin
that extends from the RecA2 domain and contacts the HA2
andOB domains. The β-hairpin (5′HP), which is a character-
istic feature of the DEAH helicases (He et al. 2017), packs
A
B
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FIGURE 1. Structure of the DHX37-RNA complex in adenosine nucleotide-free state. (A)
Schematic of the domain architecture of MmDHX37. The crystallized protein comprises resi-
dues 179–1150. (L) linker domain, (RecA1) RecA-like domain 1, (RecA2) RecA-like domain 2,
(HA2) helicase-associated domain 2, (OB) Oligonucleotide-binding fold domain, (CTD) car-
boxy-terminal domain. (B) Overall structure of the MmDHX37179–1150-U10 RNA complex.
The helicase is shown in cartoon format and colored according to the scheme in A. The bound
RNA is colored black and shown in stick format. The amino-/carboxy- and 5′-/3′-termini of the
DHX37 polypeptide and the RNA are indicated. 5′HP: 5′ hairpin motif. (C ) Zoom-in view of
RNA nucleotides U1–U4. Hydrogen bonding interactions are indicated with dashed black
lines. (D) Zoom-in view of the 5′HP and RNA nucleotides U3–U7. (E) Zoom-in view of nucleo-
tides U5–U8 binding to helicase motifs IV, Iva, and V. (F ) Zoom-in view of nucleotides U8–U10
binding to helicase motif Ic. (G) Zoom-in view of nucleotides U9–U10 binding to helicase motif
Ib (hook-turn).
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against nucleotide U5 forming a 5′-terminal bookend for
the RNA nucleotides bound in the helicase channel (Fig.
1D). The 5′HP may additionally provide a physical barrier
to induce the unwinding of secondary structures in RNA
or remodeling of protein–RNA interactions during 3′–5′
translocation, as has been proposed for other SF2 super-
family RNA helicases (Büttner et al. 2007; Pyle 2008;
Ozgur et al. 2015; He et al. 2017; Tauchert et al. 2017).
Five nucleotides (U6–U10) are accommodated in the cen-
tral part of the RNA binding channel. The bases of nucleo-
tides U6–U10 form a continuous stack, while their ribose-
phosphate backbone makes numerous contacts with the
RNA binding motifs IV, V, and VI in the RecA2 domain and
motifs Ib and Ic in the RecA1 domain (Fig. 1E–G).
Specifically, motif IV contacts the phosphate group of U6
via hydrogen-bonding interaction with the backbone am-
ide of Gln475. An invariant threonine residue in motif V
(Thr613) interacts with the phosphate group of U7. Motif
IVa, also described as the hook-loop (Prabu et al. 2015),
binds the phosphate groups of U7 and U8 by hydrogen-
bonding interactions with the backbone amide and side
chain groups of Ser588, respectively (Fig. 1E). In the 3′-
proximalpartof theRNA-bindingchannel, the ribose-phos-
phatemoieties of nucleotides U9 and U10 interact with the
RecA1 domain. The backbone amide group of Arg304
makes a hydrogen-bonding interactionwith the phosphate
group of U9, while the 2′-hydroxyl group of U9 is contacted
by the side-chain carboxyl group of Asp346 (Fig. 1F). The
phosphategroupofU10 isboundbyhydrogen-bonding in-
teractions with the invariant residue Thr345 of motif Ic and
the backbone amide of Arg330 ofmotif Ib (Fig. 1F), also re-
ferred toas thehook-turn (Tauchert et al. 2017).Arg330and
Tyr331 inmotif Ib, togetherwith invariant residuePro772 in
the α15–α16 loop of the HA2 domain, line the 3′-terminal
exit of the RNA binding channel, forming a 3′-terminal
bookend for the bound RNA (Fig. 1G).
Altogether, the structure of the DHX37-U10 complex re-
veals the RNA binding mode of DHX37 in the absence of
adenosine nucleotide (ATP or ADP), which likely corre-
sponds to a nucleotide exchange state of the helicase
upon the dissociation of ATP hydrolysis products (ADP
and inorganic phosphate) and prior to the binding of the
next ATPmolecule in the catalytic cycle. The conformation
of the DHX37 helicase core and its RNA binding mode
bears resemblance to the structures of the related helicase
DHX36 bound to a DNA substrate in the absence of ATP
(Chen et al. 2018b,c), suggesting that the ATP-free confor-
mation is conserved across the DEAH helicase family
(Supplemental Fig. S6).
RNA binding mode reveals the 3′–5′ translocation
mechanism of DHX37
DEAH RNA helicases are generally thought to catalyze the
unwinding of RNA secondary structures or remodeling of
protein–RNA complexes by ATP-powered translocation
along a tracking RNA strand in the 3′–5′ direction (Ozgur
et al. 2015). In this process, the helicases cycle through
ATP-, ADP-bound, and nucleotide-free conformational
states, in which ATP nucleotide binding at the interface of
the RecA1 and RecA2 domains allosterically induces struc-
tural transitions in the RNA binding sites. Although the
translocation directionality of DHX37 (or Dhr1) has not
been formally demonstrated, Prp43, a close homolog of
DHX37 within the DEAH family (∼39% sequence identity
within the helicase cores of human DHX37 and DHX15/
Prp43), is a bona fide 3′–5′ helicase (He et al. 2017).
Structural superpositions of MmDHX37179–1150 in the nu-
cleotide-free state with Prp43 in complexes with oligo-U
RNAs and ATP analogs reveal major conformational differ-
ences in the relative orientations of the RecA1 and RecA2
domains, reflecting an open conformation of the ATPase
site in DHX37 and a closed conformation in ATP analog-
bound Prp43 (He et al. 2017; Tauchert et al. 2017).
Structural analysis using the DynDom server (Hayward
and Berendsen 1998) further indicates that the RecA2
domain of DHX37 must rotate by ∼14° with respect to
RecA1 in order to assume the ATP-bound conformation,
while the HA2 and OB domains undergo a minor ∼2° rota-
tion combined with a 2 Å shift relative to RecA1 (Fig. 2A,B).
The conformational differences between the ATP-free and
ATPanalog-boundstatesare reflected indistinctRNAbind-
ing modes observed in the complexes. Whereas DHX37 in
the ATP-free state encloses a 5-nt stack within the RNA
binding tunnel, Prp43 in the ATP-bound state accommo-
datesa4-nt stack (Fig. 2C,D). Inboth states, the5′ and3′ ter-
mini of the nucleotide stacks are supportedby the 5′HPand
motif Ib hook-turn, respectively. As a consequence of the
open conformation of the RecA1 and RecA2 domains, the
RNA-interactingmotifs in theRecA2domain, includingmo-
tif V containing Thr613, shift by one nucleotide toward the
5′ end of the RNA (Fig. 2D). Conversely, while Thr613 re-
mains in contact with the phosphate moiety of nucleotide
N, the invariant Thr345 of motif Ic that interacts with the
phosphate of nucleotide N+3 in the ATP-free state would
contact nucleotide N+2 in the ATP-bound state upon clo-
sure of the RecA1 and RecA2 domains (Fig. 2C).
Together, the structural insights provided here suggest a
model for ATP-dependent 3′–5′ translocation in DHX37
and other DEAH helicases, in which ATP binding at the in-
terface of the RecA1 and RecA2 domains induces a confor-
mational closure that is propagated to the RNA binding
channel. By maintaining interactions with motifs IV, IVa
and V and the 5′HP in RecA2, the RNA is shifted by one nu-
cleotide along RecA1 and the 3′-terminal nucleotide exits
past the hook-turn motif. Upon ATP hydrolysis and ADP/
Pi release, the helicase reverts to the open conformation,
which allows the RecA2 domain to undergo a register shift
and engage the next 5′-terminal nucleotide, while motifs
Ic and Ib (hook-turn) in RecA1 remain tightly bound to the
Boneberg et al.
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3′-terminal part of the RNA. In thismechanism, the helicase
toggles between states in which 4- and 5-nt RNA stacks are
accommodated in the RNA binding channel, which would
be consistent with an “expansion”model of helicase trans-
locationproposedbyearlier studies (Supplemental Fig. S7;
Pyle 2008; He et al. 2017; Chen et al. 2018a; Hamann et al.
2019). Notably, the model posits that ATP binding, rather
than hydrolysis, provides the power stroke for transloca-
tion. This might explain previous observations that under
presteady state conditions, yeast Dhr1 is able to unwind
short RNA duplexes in an ATP-dependent manner but in
the absence of actual ATP hydrolysis, since translocation
along a single nucleotide might be sufficient to induce du-
plex unwinding in this case (Sardana et al. 2015).
A short motif in UTP14A activates DHX37 by
stimulating its ATPase activity and enhancing RNA
binding
In yeast, the ribosome biogenesis factor Utp14 associates
with Dhr1, the ortholog of DHX37, recruiting it to the preri-
bosomalparticle and stimulating itsRNAhelicaseactivity to
facilitate the dissociation of U3 snoRNP from the maturing
40S ribosomal subunit (Zhu et al. 2016). Utp14 directly in-
teracts with Dhr1 in vitro and enhances its RNA unwinding
activity (Zhu et al. 2016). To investigate whether the mam-
malian ortholog UTP14A has a similar effect on DHX37,
we coexpressed MmDHX37179–1150 together with full-
length human UTP14A in baculovirus-infected insect cells
and succeeded in purifying the resulting complex, confirm-
ing a direct physical interaction between DHX37 and
UTP14A (Supplemental Fig. S8). We subsequently mea-
sured the ATPase activity of isolated MmDHX37179–1150
and the MmDHX37179–1150–UTP14A complex. At physio-
logical ATP concentrations (2 mM), the ATPase activity of
the MmDHX37179–1150-UTP14A complex was ∼15-fold
higher than that ofMmDHX37179–1150 alone (Supplemental
Fig. 9A,B; Supplemental Table S1), suggesting that
UTP14A functions as an activator of DHX37 in part by in-
creasing its RNA-dependent ATPase activity. This result
stands in contrast to a previous observation that yeast
Utp14 increases the RNA unwinding activity of Dhr1 in vitro
A B
C D
FIGURE 2. RNA bindingmode of DHX37 suggests a mechanism for ATP-driven 3′–5′ translocation. (A) Side-by-side comparison of the structures
of the DHX37-RNA (left) and Prp43-RNA-ADP.BeF3
− (PDB entry 5LTA, right) complexes. The helicases were superimposed using their RecA1 do-
mains and are shown in identical orientations. (B) Superposition of DHX37 (colored as in A) and Prp43 (colored gray). The ADP.BeF3
− transition
state mimic is shown in stick format. (C ) Side-by-side views of the RNA binding channels in the DHX37-RNA (left) and Prp43-RNA-ADP.BeF3
−
(right) complexes. While DHX37 accommodates a 5-nt stack (U6–U10) in the ATP-free state, Prp43 accommodates a 4-nt stack (U4–U7) in the
ADP.BeF3
− bound state. Motif IVa is omitted from the figures to give unobstructed view of the bound RNA. (D) Superposition of the RNA binding
channels in DHX37 (colored as in A) and Prp43 (gray).
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without affecting ATPase activity (Zhu et al. 2016) but is in
good agreement with a recent study of human DHX37
(Choudhury et al. 2018). Although DHX37 and Dhr1 have
similar biological functions, it is possible that theyusediver-
gent molecular mechanisms.
Recent structural studies of the yeast SSU processome
showed that Utp14 is an intrinsically unfolded, extended
protein whose amino-terminal and carboxy-terminal re-
gions participate in SSU processome assembly by making
extensive contacts with other ribosome biogenesis factors
including Utp6, Sof1, and Utp7 (Barandun et al. 2017;
Cheng et al. 2017; Black et al. 2018). The intervening re-
gion (Supplemental Fig. S10A), which is disordered in the
SSU processome structures, has been shown to be
necessary for interaction with Dhr1 (Zhu et al. 2016).
To define the region in human UTP14A responsible
for interaction with DHX37, we expressed a series of trun-
cated protein constructs in human cells and tested their
binding to immobilized MmDHX37139–1150 in a pull-down
assay. A UTP14A protein fragment comprising residues
Lys555–Ser619 was efficiently coprecipitated by
MmDHX37139–1150 (Fig. 3A), while further amino- and
carboxy-terminal truncations abolished binding (Fig. 3B),
suggesting that this region (hereafter referred to as
UTP14Amin) is theminimalmotif necessary and sufficient for
interaction with DHX37. Purified recombinant UTP14Amin
protein was also sufficient to activate DHX37 in vitro, en-
hancing its ATPase activity by a factor of ∼14, indicating
that the stimulatory effect can be attributed solely to the
minimal region necessary for physical interaction with
DHX37 (Supplemental Fig. S9C,D; Supplemental Table
S1). UTP14Amin contains two conserved sequence motifs;
the amnio-terminal motif (Met558–Leu561) is conserved
in metazoan DHX37 orthologs, while the carboxy-terminal
motif (Met594–Glu597) is highly conserved across all
eukaryotes including yeast (Supplemental Fig. S10B).
Mutation of the amino-terminal motif residues to alanine
reduced binding to MmDHX37139–1150, while mutation of
the carboxy-terminal motif completely abolished interac-
tion with MmDHX37139–1150 (Fig. 3B). Accordingly, the
carboxy-terminal motif mutant UTP14Amin protein failed
to stimulate the RNA-dependent ATPase activity of
MmDHX37179–1150 in vitro, while the activating effect of
the amino-terminal motif mutant protein was substantially
reduced (Supplemental Fig. 9C,D). Together, these exper-
iments demonstrate that aconservedmotif in the central re-
gion of UTP14A physically interacts with DHX37 and
allosterically activates its ATPase activity. This is consistent
with prior genetic experiments showing that point muta-
tions and deletions in the corresponding region of yeast
Utp14 perturb its interaction with Dhr1 and impair the
function of Dhr1 in ribosome biogenesis (Zhu et al.
2016). Although UTP14A orthologs contain a highly con-
served glycine-rich sequence (Gly630–Gly638 in human
UTP14A, Supplemental Fig. S10B) somewhat reminiscent
of the G-patch protein consensus motif, our deletion anal-
ysis indicates that this sequence in UTP14A is neither
required for the interaction with DHX37 nor for the en-
hancement of its ATPase activity. This suggests that
UTP14A is not a canonical G-patch protein, as proposed
previously (Zhu et al. 2016).
To investigate the mechanism underpinning UTP14A-
mediated activation ofDHX37, weanalyzed theATPase ac-
tivities of MmDHX37179–1150 and the MmDHX37179–1150–
UTP14Amin complex as a function of ATP and RNA con-
centrations. UTP14Amin enhanced the ATPase activity of
DHX37 in the presence of 1.5 µM U10 RNA by increasing
kcat by approximately eightfold, while simultaneously re-
ducing the Michaelis constant (KM) for ATP by ∼2.7-fold
(Table 1; Fig. 3C). The half-maximal effective concentra-
tion (EC50) of U10 RNA was reduced by a factor of
∼60-fold in the presence of UTP14Amin (Table 1; Fig. 3D).
Together, these results suggest that UTP14A-mediated
stimulation of the RNA-dependent ATPase activity of
DHX37 is in large part due to enhancement of RNA bind-
ing. To corroborate our kinetics measurements, we exam-
ined the ssRNA binding activities of MmDHX37179–1150
and theMmDHX37179–1150–UTP14Amin complex in the ab-
sence and presence of adenosine nucleotides using fluo-
rescence polarization (FP) (Fig. 3E). In the absence of
adenosine nucleotides, UTP14Amin stimulated the binding
of U10 RNA by approximately twofold. However, in the
presence of ADP or AMPPNP, the MmDHX37179–1150–
UTP14Amin complexdisplayeda∼25-foldor∼10-fold high-
er affinity, respectively, for U10 than MmDHX37
179–1150
alone (Fig. 3E). This indicates that the interaction with
UTP14A increases the nucleotide-dependent RNAbinding
activity of DHX37 and that the increase is commensurate
with the observed enhancement of ATPase activity engen-
dered by UTP14A (Supplemental Fig. S9). Collectively,
these results imply that UTP14A stimulates the activity of
DHX37 by functioning as a processivity factor that enhanc-
es nucleotide-dependent RNAbinding, thereby increasing
the mechanochemical coupling between ATP binding/
hydrolysis and RNA translocation. This mechanism thus
likely underpins the regulation of the ATP-dependent
RNA translocation activity of DHX37, which is essential
for the remodeling of the U3 snoRNA-pre-18S rRNA struc-
ture during 40S maturation.
The carboxy-terminal domain of DHX37 is essential
for UTP14A binding in vitro and ribosome
biogenesis in vivo
G-patch proteins activate DEAH RNA helicases by interac-
tions with the OB domain (Tanaka and Schwer 2005;
Lebaron et al. 2009; Chen et al. 2014; Robert-Paganin
et al. 2015; Heininger et al. 2016). As prior studies (Zhu
et al. 2016) and our biochemical experiments suggested
that UTP14A is functionally distinct from canonical G-patch
Boneberg et al.
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FIGURE 3. UTP14A stimulates ATPase activity of DHX37 and enhances RNA binding. (A, top) Schematic diagram of human UTP14A and con-
structs used for pull-down experiment. SSU-N and SSU-C denote the amino- and carboxy-terminal regions corresponding to the regions of
Utp14 bound in the yeast SSU processome structure. Red boundary denotes region corresponding to the Dhr1 interacting region in yeast
Utp14. Solid red box denotes minimal region in HsUTP14A required for interaction with DHX37. (Bottom) SDS-PAGE analysis of streptactin
pull-down experiment using StrepII-tagged MmDHX37139–1150 as bait and indicated mCherry-tagged HsUTP14A constructs as prey. UTP14A
constructs are visualized by mCherry fluorescence. (B, top) Schematic diagram of human UTP14A and constructs used for pull-down experiment.
(Bottom) SDS-PAGE analysis of streptactin pull-down experiment using StrepII-taggedMmDHX37139–1150 as bait and indicated mCherry-tagged
HsUTP14A constructs as prey.MIEF denotes theM594A/I595A/E597A/F599Aquadruple pointmutant;MIDL denotes theM558A/I559A/D560A/
L561A mutant. (C ) RNA-dependent ATPase activity of MmDHX37179–1150 or the MmDHX37179–1150–HsUTP14Amin complex as a function of ATP
concentration. The data were subjected toMichaelis–Menten analysis and the calculated kcat and KM values are provided in Table 1. Experiments
were performed in triplicates, with data points indicating the mean and error bars indicating the standard error of the mean. (D) RNA-dependent
ATPase activity ofMmDHX37179–1150 or theMmDHX37179–1150–HsUTP14Amin complex as a function of U10 RNA concentration. Experiments were
performed in triplicates, with data points indicating themean and error bars indicating the standard error of themean. EC50 values are provided in
Table 1. (E) Fluorescence-polarization equilibrium binding assays of MmDHX37179–1150 or the MmDHX37179–1150–HsUTP14Amin complex with
ATTO532 fluorophore-labeled U12 RNA in the absence of adenosine nucleotides (left) and in the presence of ADP (center) and the nonhydrolyz-
able ATP analog AMPPNP (right). Kd values are provided in Table 1.
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proteins, we next sought to pinpoint the specific domains
in DHX37 involved in the interaction with UTP14A, focus-
ing on the unique CTD of DHX37. We expressed
full-length MmDHX37 and a truncated variant comprising
amino acid residues 2-1003 (MmDHX37ΔCTD) in human
cells and tested their binding to immobilized UTP14Amin
in a pull-down experiment. Whereas MmDHX37 was
efficiently coprecipitated by UPT14A from cell lysate,
MmDHX37ΔCTD was not, indicating that the CTD is re-
quired for stable interaction with UTP14A (Fig. 4A). The
RNA-dependent ATPase activity of MmDHX37ΔCTD was
similar to that of MmDHX37179–1150 (Supplemental Fig.
S11A). Crucially, the ATPase activity was not enhanced in
the presence of UTP14A, indicating that the CTD is re-
quired both for the interaction with UTP14A and for
UTP14A-mediated stimulation of the ATPase activity of
DHX37 (Supplemental Fig. S11A). However, subsequent
pull-down experiments revealed that purified recombinant
DHX37 CTD (comprising amino acid residues 1003–1150)
did not interact with UTP14Amin (Supplemental Fig. S11B,
C), indicating that although essential, the CTD is not suffi-
cient to mediate a stable interaction with UTP14A.
To further test the requirement of the CTD for the func-
tion ofDHX37 in ribosomebiogenesis, weused a previous-
ly established reporter assay to examine the effect of
overexpressing wild-type and mutant MmDHX37 proteins
on the biogenesis of the 40S subunit. In this assay, nucleo-
lar retention of the biogenesis factor ENP1 upon treatment
with the nuclear export inhibitor LMB is indicative of an ear-
ly 40S biogenesis defect (Badertscher et al. 2015). Overex-
pression of the ATPase-deficient E369Q point mutant
resulted in nucleolar retention of ENP1, indicating that cat-
alytically inactive DHX37 acts as a dominant-negative in-
hibitor of 40S biogenesis (Fig. 4B; Supplemental Fig.
S11D). In contrast, overexpression of neither full-length
wild-type MmDHX37 nor a catalytically active MmDHX37
lacking the CTD (MmDHX37ΔCTD) had a dominant-nega-
tive effect on 40S biogenesis. Notably, nucleolar localiza-
tion of MmDHX37ΔCTD was not perturbed, indicating that
the protein is folded and the CTD is not required for the
nuclear import of DHX37 (Fig. 4B). To complement these
results, we tested the ability of ectopically expressed full-
length andMmDHX37ΔCTD proteins to rescue the 40S bio-
genesis defect caused by depletion of endogenous
DHX37 in HeLa cells. To this end, we utilized CRISPR inter-
ference to target the promoter of the endogenous DHX37
gene, thereby down-regulating its expression, in cells sta-
bly transfected with MmDHX37 expression plasmids (Sup-
plemental Fig. S11E). CRISPRi-targeted cells expressing
MmDHX37ΔCTD exhibited nucleolar localization of ENP1
in the presence of LMB, indicating that MmDHX37ΔCTD
was unable to rescue the early 40S biogenesis defect phe-
notype caused by DHX37 depletion, whereas expression
of full-length MmDHX37 restored normal localization of
ENP1 (Fig. 4C). Together, these observations indicate
that the CTD of DHX37 is required for 40S biogenesis in
vivo.
The current model for the function of DHX37/UTP14A,
based on genetic and biochemical studies of yeast
Dhr1/Utp14 (Zhu et al. 2016), posits that DHX37 is
TABLE 1. Kinetic and thermodynamic parameters of DHX37 and the DHX37-UTP14A complex
Enzyme RNA Km (µM) kcat (s
−1)
ATPase activity
MmDHX37179–1150 — 28.30±2.92 0.0108±0.0001
MmDHX37179–1150 (1.0 µM) U10 (1.5 µM) 19.26±4.79 0.105±0.003
MmDHX37179–1150 +UTP14Amin (0.125 µM) U10 (1.5 µM) 52.61±4.78 0.844±0.009
MmDHX37179–1150 +UTP14Amin (0.125 µM) U10 (0.188 µM) 19.95±0.75 0.301±0.001
Enzyme EC50 (µM)
EC50 of U10 RNA for ATPase activation (ATPase activity measured at 1 mM ATP)
MmDHX37179–1150 13.27±1.08
MmDHX37179–1150 +UTP14Amin 0.22±0.03
Enzyme Nucleotide Kd (nM)
Equilibrium dissociation constants for U10 RNA binding
MmDHX37179–1150 — 9.83±0.55
MmDHX37179–1150 +UTP14Amin — 4.19±0.27
MmDHX37179–1150 ADP (1 mM) 2133±316
MmDHX37179–1150 +UTP14Amin ADP (1 mM) 86.06±13.8
MmDHX37179–1150 AMPPNP (1 mM) 135.13±2.41
MmDHX37179–1150 +UTP14Amin AMPPNP (1 mM) 14.61±0.26
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FIGURE 4. The CTD of DHX37 is required for interaction with UTP14A in vitro and for ribosome biogenesis in vivo. (A) Pull-down experiment
using recombinant maltose-binding protein-tagged UTP14Amin and full-length and ΔCTD MmDHX37 expressed in HEK293 cells.
(B) Immunofluorescence analysis of the localization of the 40S subunit assembly factor ENP1 in HeLa cells expressing wild-type EGFP-
MmDHX37, a truncated version lacking the carboxy-terminal domain (ΔCTD), or the ATPase-deficient E369Q mutant. Expression of DHX37 pro-
teins was induced with tetracycline for 24 h. Ninety minutes before fixation, cells were either supplemented with a solvent control or with 20 nM
leptomycin B (LMB) to prevent CRM1-dependent nuclear export, leading to nucleoplasmic accumulation of ENP1 along with newly made 40S
subunits in control cells (Badertscher et al. 2015). Note that the E369Qmutant prevents relocalization of ENP1 to the nucleoplasm in the presence
of LMB, indicative of early 40S subunit maturation defects. (C ) The CTD of DHX37 is required to rescue early 40S biogenesis defects upon DHX37
depletion. DHX37 was depleted from HeLa cells by CRISPRi. HeLa cells were left untreated (−) or transfected for 72 h with a plasmid encoding
HA-tagged dCas9 and either a sgRNA targeting endogenous DHX37 (DHX37i) or a control sgRNA and transfected cells were selected with pu-
romycin. Expression of the indicated EGFP-MmDHX37 rescue constructs was induced for 24 h with tetracycline. Cells were treated with LMB for
90 min before fixation as indicated. The expression of HA-tagged dCas9 and localization of the 40S assembly factor ENP1 were analyzed by im-
munofluorescence. Scale bars, 20 µM.
www.rnajournal.org 693
recruited to the maturing 40S subunit in part by interac-
tions with UTP14A and its ATP-dependent helicase activity
is subsequently activated by UTP14A to promote the re-
moval of U3 snoRNA, which triggers pre-18S rRNA folding
and is required for ITS1 cleavage. In light of the results of
the overexpression and rescue experiments, we conclude
that the CTD of DHX37 is critical for this process. As with
Dhr1 in yeast (Granneman et al. 2006; Sardana et al.
2015), overexpression of ATPase-deficient DHX37 inhibits
40S biogenesis, presumably because the helicase can still
be recruited to the preribosomal particle but is unable to
catalyze the removal of U3 snoRNA. Since DHX37 lacking
the CTD is unable to exert the dominant-negative effect on
40S biogenesis, yet fails to rescue the phenotype caused
by DHX37 depletion, our interpretation is that the CTD is
required for UTP14A-dependent recruitment and activa-
tion of the helicase.
Conclusions
RNA helicases, including DHX37/Dhr1, play indispensable
roles in ribosome biogenesis. In this study, we determined
the crystal structure of the DHX37-RNA complex in the nu-
cleotide-exchange state, providing insights into themolec-
ular mechanism for the ATP-dependent RNA translocation
activity of DHX37 required for U3 snoRNA removal during
40S subunit maturation. Comparisons with structures of
DHX36 and Prp43 in their respective nucleotide-free and
the ATP-bound states suggest that ATP binding induces
DHX37 to convert from an open conformation, in which a
5-nt RNA segment is accommodated in the RNA binding
channel, to a closed conformation in which a 4-nt RNA seg-
ment is bound (Supplemental Fig. S7). Our structural in-
sights thus lend further support to a mechanistic model
for DEAH helicases in which conformational cycling be-
tween ATP-bound and nucleotide-free states results in
directional 3′ to 5′ translocation along single-stranded
RNA, which is coupled to RNA duplex unwinding or RNP
remodeling.
Recent studies have suggested that UTP14A functions as
a ribosomebiogenesis factor in part by recruitingDHX37 to
the maturing preribosomal particle (Choudhury et al.
2018). Our biochemical experiments reveal that a con-
served motif in UTP14A, distinct from the canonical
DEAH-interacting motif found in G-patch proteins, is nec-
essary and sufficient for interaction with DHX37. The motif
is part of the central region of UTP14A that is likely to be ex-
posed on the surface of the SSU processome, poised to
mediate DHX37 recruitment. In turn, interaction with
UTP14A is mediated in part by the structurally unique
CTD inDHX37, which is also required for ribosomebiogen-
esis. Finally, our work suggests that UTP14A stimulates the
activity of DHX37 by acting as a processivity factor that en-
hances RNA binding and the coupling between ATPase
and RNA translocase/remodeling activities. Together,
these insights provide a mechanistic rationale for the coor-
dination of DHX37 recruitment and activation in driving a
key step in 40S subunit maturation and have implications
for other DEAH helicases involved in ribosome biogenesis,
such as Prp43. Determining the structural basis of the
UTP14A–DHX37 interaction will be an important future
step toward understanding the regulation of not only
DHX37 but DEAH helicases in general.
MATERIALS AND METHODS
Protein expression and purification
All constructs usedwere cloned intoMacroLab vectors developed
by Scott Gradia (University of California, Berkeley) using ligation-
independent cloning. Full-length murine DHX37 (MmDHX37)
and an amino-terminally truncated fragment of murine DHX37 en-
compassing residues 179–1150 (MmDHX37179–1150) were inserted
into the MacroLab vector 438B (Addgene #55219), in frame with
an amino-terminal His6-tag cleavable using Tobacco Etch Virus
(TEV) protease. Full-length human UTP14A (HsUTP14A) was in-
serted into the 438Rgfp vector (Addgene #55221) in frame with
an amino-terminal (StrepII)-GFP-tag. The 438Rgfp-HsUTP14A
construct was combined with 438B-MmDHX37179–1150 into a sin-
gle plasmid for subsequent coexpression in insect cells and copur-
ification (Gradia et al. 2017). An amino-terminally truncated
fragment of murine DHX37 encompassing residues 139–1150
(MmDHX37139–1150) was inserted into a modified 5B vector
(Addgene #30122) with an amino-terminal His6-(StrepII)2-tag.
The CTD of murine DHX37, encompassing residues 1003–1150
(MmDHX37CTD), was inserted into MacroLab vector 2G-T
(Addgene #29707) in fusion with an amino-terminal His6-GST-
tag. A truncated construct of human HsUTP14A encompassing
residues 555–619 (HsUTP14Amin) was inserted into MacroLab
vector 1M (Addgene #29656) in fusion with an amino-terminal
His6-MBP-tag. All DHX37 constructs, except MmDHX37
CTD
were expressed in Sf9 insect cells using the Bac-to-Bac system
(Invitrogen) according to standard protocols. Briefly, Sf9 insect
cells were infected with P3 virus (2.5 mL per 0.5 L) at a density of
1.0×106 mL−1. Sixty-four hours after infection Sf9 cells were har-
vested and resuspended in Sf9 lysis buffer (20 mM Tris pH 8.0,
500 mM NaCl, 5 mM imidazole, 0.1% Tween 20, supplemented
with Roche Protease Inhibitor Cocktail; 50 mL per 1 L of culture).
Cells were lysed for 25 min by sonication (20% amplitude, 3 sec
pulse on, 17 sec pulse off, 4°C) and lysates were clarified at
18,000g for 30 min at 4°C.
Full length His6-MmDHX37, His6-MmDHX37
179–1150, and
His6-MmDHX37
179–1150/StrepII-GFP-HsUTP14A complex were
purified by Nickel affinity chromatography (Ni2+-NTA-sepharose
resin; Qiagen). The column was washed with Ni-wash buffer (20
mM Tris pH 8.0, 500mMNaCl, 20 mM imidazole) and bound pro-
tein was eluted with Ni-elution buffer (20mMTris pH 8.0, 150mM
imidazole, 250 mM NaCl for MmDHX37179–1150 ; 20 mM Tris pH
8.0, 150 mM imidazole, 500 mM NaCl for MmDHX37 and the
His6-MmDHX37
179–1150/StrepII-GFP-HsUTP14A complex). The
protein was subsequently cleaved with Tobacco Etch Virus (TEV)
protease while dialyzed overnight at 4°C against 20 mM Tris pH
7.5, 250 mM NaCl (500 mM NaCl for MmDHX37 and complex),
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1 mM TCEP pH 7.0 [Tris(2-carboxyethyl)phosphine hydrochlo-
ride]. In a second Ni-affinity chromatography step uncleaved
His6-protein, His6-tagged TEV, and free His6-tag were removed.
After the second Ni-affinity step, the NaCl concentration in the
flow-through fraction was reduced to 250 mM using K0 buffer
(20 mM Tris pH 7.5, 1 mMDTT) if necessary. The cleaved proteins
were subjected to cation exchange chromatography using a
Heparin column (HiTrap Heparin, GE Healthcare). The column
was washed using IEX buffer A (20 mM Tris pH 7.5, 100 mM
NaCl, 1 mM DTT) and protein was eluted by applying a gradient
from 0% to 100% IEX buffer B (IEX buffer B: 20 mM Tris pH 7.5,
1000 mM NaCl, 1 mM DTT) over 20 column volumes. DHX37
was finally purified by a size exclusion chromatography step using
a Superdex 200 column and eluted in 20 mM HEPES pH 7.5, 250
mM KCl (350 mM KCl for MmDHX37 and MmDHX37179–1150/
HsUTP14A complex), 1 mM DTT. Eluted protein samples were
concentrated and flash frozen with liquid nitrogen and stored at
−80°C.
GST-tagged MmDHX37CTD fusion protein was expressed in
E. coli Rosetta 2 DE3 cells (Novagen, Merck Millipore) for 4 h
at 37°C after induction with 0.2 mM IPTG (Isopropyl-β-D-thioga-
lactopyranoside). The protein was resuspended in lysis buffer
(15 mL per 1 L culture; 20 mM Tris pH 8.0, 500 mM NaCl,
1 mM DTT) and lysed using a cell homogenizer (HPL6 cell ho-
mogenizer; passed three times, 4°C). Cell lysates were clarified
at 18,000g for 30 min at 4°C. GST-tagged MmDHX37CTD was
purified by glutathione (GSH) affinity chromatography. The
bound protein was washed with wash buffer (20 mM Tris pH
8.0, 500 mM NaCl, 1 mM DTT) and eluted in lysis buffer supple-
mented with 10 mM reduced GSH. MmDHX37CTD was finally pu-
rified by a size exclusion chromatography step using a Superdex
200 column and eluted in 20 mM HEPES pH 7.5, 250 mM KCl,
1 mM DTT. The protein was flash frozen with liquid nitrogen
and stored at −80°C.
His6-(StrepII)2-MmDHX37
139–1150 was purified by Nickel affinity
chromatography as described above and dialyzed overnight at
4°C against 20 mM Tris pH 7.5, 250 mMNaCl, 1 mMDTT without
tag cleavage. The protein was flash frozen with liquid nitrogen
and stored at −80°C. Catalytic inactive MmDHX37179–1150_E369Q
(MmDHX37EQ) construct was generated by site-directed muta-
genesis (QuikChange) using 438B-MmDHX37179–1150 as PCR
template, and expressed and purified as His6-MmDHX37
179–1150.
His6-MBP-HsUTP14A
min fusion protein was expressed in
Rosetta 2 DE3 cells (Novagen, Merck Millipore) for 4 h at 37°C
after induction with 0.2 mM IPTG. The protein was resuspend-
ed in Ni-NTA lysis buffer (15 mL per 1 L culture; 20 mM Tris pH
8.0, 250 mM NaCl, 5 mM imidazole) and lysed using a cell
homogenizer (HPL6 cell homogenizer; passed three times,
4°C). Cell lysates were harvested and purified by Ni-NTA affinity
chromatography as described above. Before flash freezing, the
imidazole concentration of the protein sample was adjusted to
30 mM imidazole. The protein sample was stored at −80°C.
HsUTP14A alanine substitution mutant constructs, His6-MBP-
HsUTP14Amin_MIDL and His6-MBP-HsUTP14A
min_MIEF, were gen-
erated using inverse PCR with 1M-HsUTP14Amin as PCR tem-
plate, and expressed and purified as His6-MBP-HsUTP14A
min.
To reconstitute MmDHX37179-1150/UTP14Amin complex, a
twofold molar excess of His6-MBP-HsUTP14A
min was added
to MmDHX37179–1150 and incubated at room temperature for
10 min.
Crystallization and data collection
Crystals of MmDHX37179–1150 bound to U10 RNA were grown by
the hanging drop vapor diffusion method by mixing equal
volumes (1 µL+1 µL) of MmDHX37179–1150 (preincubated at a
concentration of 7 mg mL−1 with 1.5-fold molar excess of single-
strandedU10 RNA, 1mMAMPPNPand 2.5mMMgCl2), and reser-
voir solution containing 0.1 M Bis-Tris propane pH 7.0, 0.2 M
NaNO3, 15% (w/v) polyethylene glycol (PEG) 3400 and incubation
at 20°C. The size and morphology of crystals was optimized by
microseeding. Au-derivatized crystals were obtained by soaking
native crystals for 15 min in mother liquor supplemented with
10mMK[Au(CN)2]. Before flash cooling in liquid nitrogen, crystals
were cryoprotectedby brief soaking inmother liquor supplement-
ed with 15% (v/v) ethylene glycol. X-ray diffraction data were col-
lected at beamline X06DA (PXIII) of the Swiss Light Source (Paul
Scherrer Institute, Villigen, Switzerland). The crystals belonged
to space group P21, contained two copies of the DHX37-RNA
complex in the asymmetric unit, and diffracted to a resolution
of 2.9 Å (native crystal) or 3.0 Å (Au-derivatized crystal). For
the Au-derivatized crystal a single-wavelength anomalous dif-
fraction (SAD) experiment was performed. From a single crystal,
seven 360° data sets were measured at a wavelength of 1.03980
Å, which corresponds to the Au L-III absorption edge. The dif-
fraction data were processed using XDS (Kabsch 2010). SAD
data was additionally scaled and merged with XSCALE
(Kabsch 2010).
Structure determination, refinement,
and analysis
Structure determination was performed with the Phenix suite
(Adams et al. 2010) based on the SAD data obtained from the
Au-derivatized crystal. Twenty-seven Au sites were identified us-
ing phenix.hyss. Substructure refinement, phasing and density
modification in phenix.autosol (Zwart et al. 2008) resulted in a
clearly interpretable experimental electron density map, which
was used for manual model building with COOT (Emsley and
Cowtan 2004). The majority of DHX37 residues as well as uridine
ribonucleotides could be assigned and built into the experimen-
tal electron density map. Next, molecular replacement was per-
formed with the high-resolution native data set using phenix.
phaser (McCoy et al. 2007). Structure refinement was carried
out with phenix.refine (Afonine et al. 2012). For the initial refine-
ment round, the B-factors of the starting model were set to
40 Å2. The initial round of refinement included rigid-body refine-
ment, atomic coordinate refinement, and individual B-factor re-
finement. This was followed by iterative rounds of atomic
coordinate, TLS and individual B-factor refinement, alternated
with manual building in COOT to complete the atomic model.
Noncrystallographic symmetry restraints were applied through-
out the refinement and only released in the final round. The final
atomic model was refined at a resolution of 2.9 Å with an Rfree of
29.7% and an Rwork of 26.8%. X-ray crystallographic data collec-
tion and refinement parameters are provided in Table 2. The final
model of the DHX37-U10 complex comprises 10 uridine ribonu-
cleotides and DHX37 amino acid residues 231–1149, except for
residues 432 and 490–578, which are disordered in electron den-
sity maps. Analysis of the twoMmDHX37179–1150 molecules using
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DynDom (Hayward et al. 1997) indicates that themajor conforma-
tional difference between the two copies in the asymmetric unit
involves a rotation by 8.8° of the CTD relative to the helicase
core (comprising domains RecA1, RecA2, HA2, and OB) about a
pivot point centered on residues 1007–1008. The helicase cores
of the two DHX37179–1150 copies superimpose as rigid bodies
and align with an RMSD of 1.03 Å over 659 Cα atoms. The CTD
domains superimpose with an RMSD of 0.45 Å over 127 Cα at-
oms. Structure superpositions of DHX37 and Prp43 and DHX36
were performed using the DALI server (Holm and Sander 1995).
To model the conformation of MmDHX37 in the activated ATP-
and RNA-bound state (MmDHX37-ATP-RNA complex), individu-
al DHX37 domains (as defined in Fig. 1A), except for the CTD,
were individually superimposed with the structure of the
crPrp43-RNA-ADP.BeF3
− complex (Tauchert et al. 2017) and
combined in a single-polypeptide model. Domain motions pre-
dicted to occur during the RNA translocation cycle were subse-
quently analysed by comparing the resulting model with the
crystal structure of the nucleotide-free MmDHX37-RNA complex
in DynDom.
ATPase activity assays
The ATPase activities of DHX37 constructs in the presence and
absence of UTP14A were measured using the EnzCheck
TABLE 2. Data collection and refinement statistics
Data set
DHX37
Native Hg SAD
X-ray source SLS X06DA (PXIII) SLS X06DA (PXIII)
Space group P21 P21
Cell dimensions
a, b, c (Å) 83.83, 137.60, 94.23 83.69, 138.16, 94.89
α, β, γ (o) 90.00, 93.34, 90.00 90.00, 93.67, 90.00
Wavelength (Å) 1.0077 1.0398
Resolution (Å)a 47.03–2.88 (2.98–2.88) 45.61–2.99 (3.10–2.99)
Rmerge
a 0.112 (0.684) 0.186 (2.054)
CC1/2
a 0.996 (0.746) 0.999 (0.761)
I/σIa 13.65 (2.17) 29.47 (3.04)
Observationsa 320,411 (25,685) 2,381,443 (213,156)
Unique reflectionsa 47,756 (4209) 43,382 (4240)
Multiplicitya 6.7 (6.1) 54.9 (50.3)
Completeness (%)a 98.52 (87.65) 99.78 (98.38)
Refinement
Resolution (Å) 47.03–2.88
No. reflections 47,734 (4209)
Rwork/Rfree 0.270/0.295
No. atoms
Protein 12,605
RNA 394
B-factors (Å2)
Mean 65.3
Protein 65.2
RNA 68.2
R.m.s. deviations
Bond lengths (Å) 0.005
Bond angles (°) 0.79
Ramachandran plot
% Favored 96.8
% Allowed 3.2
% Outliers 0.0
aValues in parentheses denote highest resolution shell.
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Phosphate kit (Invitrogen) at 26°C. Here, the provided 2-amino-6-
mercapto-7-methylpurine riboside (MESG) substrate together
with the released inorganic phosphate (Pi) is enzymatically con-
verted to 2-amino-6-mercapto-7-methyl-purine which absorbs
light at 360 nm, thus, facilitating the measurement of the Pi con-
centration in the reactionmixture. All reactions were performed in
triplicates in a buffer containing 50 mM HEPES pH 7.5, 150 mM
KCl, 1 mM DTT, and 1 mM MgCl2, in a total volume of 200 µL.
For ATPase activity assays (Supplemental Figs. S1A, S9B,D,
S11A) 0. 25 µM DHX37 (and complexes) was used. For reactions
carried out in the presence of RNA, 0.25 µM single-stranded U10
RNAwas added to the protein samples, and the samples were in-
cubated for 10 min at room temperature. Reactions were supple-
mented with 0.2 U purine nucleoside phosphorylase (PNP) and
1 mM MESG according to the manufacturerś protocol. The
ATPase reactions were initiated by adding ATP and MgCl2
(both at 2 mM final concentration) to the samples. Absorbance
at 360 nm was measured once per minute over 40 min in a micro-
plate reader (PheraStar FSX fluorescence plate reader; BMG
Labtech). The absorbance values at 360 nm were corrected for
background absorbance. To quantify the released Pi, a calibration
curve was generated with the phosphate standard provided to-
gether with the kit. The resulting values were plotted as a function
of time using the GraphPad Prism software. To compare ATPase
activities between samples, data points within the linear range
were fitted with linear regression, and listed in Supplemental
Table S1. The data represent mean values from three replicates,
while the error bars indicate the standard error.
For Michaelis–Menten analysis (Fig. 3C), MmDHX37179–1150
was used at final concentrations of 2 µM in the absence of RNA
or 1 µM when assayed in the presence of U10 RNA. The
MmDHX37179–1150/UTP14Amin complex was reconstituted as de-
scribed above and assayed at a final concentration of 0.125 µM.
For experiments carried out in the presence of RNA, a 1.5-fold
molar excess of U10 RNA was added. ATP was used at concentra-
tions of 7.8125–1000 µM. ATPase activities were normalized for
DHX37 concentrations to allow direct comparisons. The data rep-
resent mean values from three replicates, while the error bars in-
dicate the standard error. KM and kcat values were fitted according
to the Michaelis–Menten equation in GraphPad Prism and are
provided in Table 1.
To investigate the effect of RNA on ATPase activity (Fig. 3D),
MmDHX37179–1150 and the MmDHX37179–1150/UTP14Amin com-
plex were used at a final concentration of 0.5 µM , ATP at a final
concentration of 1 mM, and U10 RNA was titrated to final concen-
trations of 0.1–12.8 µM. Absorbance values at 360 nm were re-
corded every 15 sec for 25 min and quantified using the
phosphate standard as described above. Initial reaction rates
were calculated from the linear region of the absorbance curve.
The resulting values were plotted as a function of ATP concentra-
tion (or RNA concentration) using GraphPad Prism and fitted by
nonlinear regression analysis using the dose-versus-response re-
lationship to calculate half-maximal effective concentration
(EC50) values.
Equilibrium RNA binding experiments
RNA binding affinities of DHX37 in the presence and absence of
UTP14A were determined by FP measurements with 5′-
ATTO532-labeled U12 RNA at 26°C using a PheraStar FSX fluores-
cence plate reader. All reactions were carried out in triplicates in a
buffer containing 20 mM HEPES pH 7.5, 150 mM KCl, 2 mM
MgCl2, and 0.1% Tween20, in a total volume of 50 µL. NaCl,
MgCl2, and Tween20 concentrations of the protein samples
were adjusted to 150mM, 2mM, and0.1%Tween20, respectively,
using 1.5x K50 buffer (20 mM HEPES pH 7.5, 50 mM KCl, 3 mM
MgCl2, and0.15%Tween20.MmDHX37
179–1150/UTP14Amin com-
plex was reconstituted as described above. For the RNA binding
measurements, 0.25 nM Atto532-labeled U12 RNA were titrated
with MmDHX37179–1150 or MmDHX37179-1150/UTP14Amin com-
plex at varying concentrations ranging from 0.27 nM to 17.5 µM.
Formeasurements performed in the presenceof adenosine nucle-
otides, ADP and AMPPNP were added at final concentrations of 1
mM. The AMPPNP stock (Jena Bioscience) was analysed by HPLC
prior to its usage and estimated to be >95% pure. Fluorescence
polarization (FP) signal was measured with an excitation filter
with a central wavelength of 540 nm, and P and S emission filters
with a central wavelength of 590 nm. The resulting FP values
were plotted using the Graphpad Prism software as a function of
concentration and fitted to a modified one-site binding equation
accounting for ligand depletion:
Y = i + (a− i) . (c + K + X )−
√
((−c − X − K )2 − 4cX )
2c
( )
,
where K is the Kd to be determined, c is the total concentration of
Atto532-labeled RNA, i is the Ymin value, and a is the Ymax value.
The polarization amplitudes were normalized to 1. Error bars indi-
cate standard errors of the mean (SEM) for five consecutive mea-
surements of a single representative sample. The calculated Kd
values are provided in Table 1.
RNA pull-down experiment
For the RNA binding assay, 3 µg of MmDHX37179–1150 were incu-
bated in binding buffer (20 mM HEPES pH 7.5, 150 mM KCl,
2 mM MgCl2, 0.1% Tween20, 1 mM DTT) in the presence or ab-
sence of 1 mM adenosine nucleotides (AMPPNP or ADP)
and 333 nM 5′ end biotinylated U20 single-stranded RNA in a
volume of 30 µL. After 60 min incubation at 4°C, 50 µL magnetic
streptavidin coupled beads (Streptavidin-coupled Dynabeads,
ThermoScientific) and 200 µL of binding buffer (supplemented
with or without 1 mM AMPPNP and ADP) were added. The sam-
ples were incubated with the beads for 1 h at 4°C. Beads were
washed three times with 0.5 mL binding buffer and samples
were eluted in SDS dye. Analysis of the eluted samples was
done by SDS-PAGE.
DHX37-UTP14A pull-down experiments
HEK293T cells were grown in DMEM supplemented with 10% fe-
tal bovine serum, 100 U mL−1 penicillin/streptomycin (Sigma), 2
mM L-glutamine (Sigma) and 100 µg mL−1 sodium pyruvate at
37°C and 5% CO2. For overexpression in mammalian HEK293T
cells, full-length HsUTP14A and truncations were PCR amplified
and were cloned into a homemade plasmid based on the liga-
tion-independent MacroLab vector 6A (Addgene #30124),
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adding an amino-terminal His6-(HA)3-mCherry-tag. HsUTP14A
min
multi-alanine binding mutants M558A/I559A/D560A/L561A,
(HsUTP14Amin_MIDL) and M594A/I595A/E597A/F599A (HsUT
P14Amin_MIEF) constructs were generated by inverse PCR.
Transfections were performed in 10-cm dishes seeded with 2×
106 cells using the X-tremeGENE HP DNA Transfection Reagent
(Roche) and 3–4.5 µg plasmid DNA per transfection. HEK293T
cells were collected 48 h post-transfection, washed twice with
PBS and resuspended in 1.5 mL assay buffer (20 mM Tris pH
7.5, 150 mM KCI, 1 mM EDTA, 0.1% [v/v] Tween20, 1 mM DTT)
supplemented with Roche Protease Inhibitor Cocktail. The cells
were detached by gentle rocking at 4°C for 10 min and lysed
by sonication (10% amplitude, 0.5 sec pulse on, 2 sec pulse off,
15 times, 4°C). The lysates were cleared by two centrifugation
steps at 14,000 rpm for 15 min and incubated with 5 µg/mL
RNAse A (Thermo Fisher) for 20 min on ice. Per reaction, 25 µL
(packed volume) Strep-Tactin Sepharose beads (IBA) were incu-
bated with 250 µg of His6-(StrepII)-MmDHX37
139–1150 for
30 min at 4°C and washed three times with HEK assay buffer.
For the pull-downs, 450 µL of cleared HEK293T cell lysates
were incubated with 25 µL MmDHX37-Strep-beads for 1 h at
4°C. For the no bait control, 25 µL Strep-beads without
MmDHX37 were incubated with 450 µL HEK293T cell lysate.
The beads were washed four times with HEK293T assay buffer
and bound proteins were eluted in two 10 min-steps on ice with
15 µL elution buffer (20 mM Tris pH 8.0, 150 mM KCl, 1 mM
EDTA, 2.5 mM desthiobiotin) each. The eluted samples and the
input lysate were loaded on SDS-PAGE without prior boiling to
avoid mCherry denaturation, visualized on a Typhoon FLA9500
fluorescence scanner (GE Healthcare) and subsequently stained
with Coomassie brilliant blue R250.
For MBP pull-down experiments, 10 µg of MBP-tagged
UTP14Amin were immobilized on 50 µL (50% slurry) of amylose res-
in (NEB) in a binding buffer containing 20mMTris pH 7.5, 150mM
KCl, 1 mMDTT and 0.1% Tween 20. The beads were washed and
incubated with 15 µg of GST-tagged MmDHX37CTD in binding
buffer for 1 h at 4°C with gentle rocking. Subsequently the beads
were washed four times with 1 mL of binding buffer and proteins
were eluted by boiling the resin with 20 µL of SDS-PAGE sample
buffer. Proteins were analyzed by SDS-PAGE and visualized by
Coomassie staining. For GST pull-down experiments, 10 µg of
GST-tagged MmDHX37CTD were immobilized on 50 µL (50%
slurry) of glutathione resin (GE Healthcare) in binding buffer. The
beads were washed and incubated with 15 µg of MBP-tagged
HsUTP14A555–619 in binding buffer for 1 h at 4 °Cwith gentle rock-
ing. The beadswerewashed four timeswith 1mLof binding buffer
and proteins were eluted by boiling the resin with 20 µL of SDS-
PAGE sample buffer. Proteinswere analyzedby SDS-PAGEand vi-
sualized by Coomassie staining.
DHX37 plasmid constructs for mammalian cell
expression
For expression in mammalian cells (HEK293 and HeLa FlpIn TREx
cells), full-length MmDHX37 and MmDHX37 encompassing resi-
dues 2–1003 (MmDHX37ΔCTD) were PCR-amplified and sub-
cloned into a modified pcDNA5/FRT/TO expression vector,
adding an amino-terminal EGFP-tag (EGFP-MmDHX37WT and
EGFP-MmDHX37ΔCTD) or an amino-terminal HA-(Strep)2-tag
(HASt-MmDHX37ΔCTD). The EGFP fragment was inserted into
the KpnI/HindIII sites of pcDNA5TM/FRT/TO (Invitrogen).
Catalytically inactive MmDHX37 was generated by PCR using
EGFP-MmDHX37WT as PCR template (EGFP-MmDHX37EQ).
DHX37ΔCTD-UTP14A pull-down experiments
Transfections of HEK293T cells were performed as described
above. Briefly, 3 µg plasmid DNA (EGFP-MmDHX37wt and
EGFP-MmDHX37ΔCTD) were transfected in HEK293T cells at a
density of 2×106 cells using 9 µL of the X-tremeGENE HP DNA
Transfection Reagent (Roche). Forty-eight hours posttransfec-
tions, cells were harvested and lysed in 1.5 mL assay buffer
(20 mM Tris pH 7.5, 150 mM KCl, 1 mM EDTA, 0.1% [v/v]
Tween20, 1 mM DTT) supplemented with Roche Protease
Inhibitor Cocktail, in the presence of RNAse A (Thermo Fisher).
Per reaction, 50 µL (packed volume) Amylose beads (NEB) were
incubated with 2 mg of recombinant His6-MBP-HsUTP14A
min
for 30 min at 4°C and washed three times with HEK assay buffer.
For the pull-downs, 500 µL of cleared HEK293T cell lysates were
incubated with 50 µL His6-MBP-HsUTP14A
min-Amylose-beads
for 1 h at 4°C. For the no bait control, 50 µL Amylose-beads with-
out His6-MBP-HsUTP14A
555–619 were incubated with 500 µL
HEK293T cell lysate. The beads were washed four times with
HEK293T assay buffer and bound proteins were eluted in 1×
SDS-PAGE sample loading dye supplemented with 10 mM malt-
ose. Proteins were separated by SDS-PAGE with no prior boiling
to avoid EGFP denaturation, visualized on a Typhoon FLA9500
fluorescence scanner (GE Healthcare) and subsequently stained
with Coomassie brilliant blue R250.
Expression and purification of DHX37ΔCTD
HASt-MmDHX37ΔCTD was expressed in suspension-adapted
HEK293S-GnTI− cells (ATCC CRL-3022). Cells were grown in
HyClone TransFx-H media (Sigma) supplemented with 2 mM
L-glutamine (Sigma), 100 U mL–1 penicillin/streptomycin
(Sigma), 1% FBS (Sigma), and 1% Pluornic F-68 (Thermo Fisher)
at 37°C and 5% CO2 while shaking at 185 rpm in TubeSpin
Bioreactor 600 vessels. One day prior to transfection, cells were
diluted to a density of 0.7× 106 cells mL−1. Transfection mix
was prepared by diluting plasmid DNA (1.3 µg DNA per 106 cells)
to 0.015 µg µL−1 in DMEMmedia, andmixing it with 25 kDa linear
polyethylenimine (PEI, Polysciences) at a concentration of 0.38 µg
µL−1. After incubation for 10 min, the DNA-PEI complexes were
diluted 10-fold into the cultured cells, and valproic acid (Sigma)
was added to a final concentration of 3 mM. Forty-five hours post-
transfection, cells were harvested by centrifugation at 500g for
10 min and washed with PBS. The cells were resuspended in lysis
buffer (20 mM Tris pH 7.5, 350 mM KCl, 1 mM DTT, 0.05%
Tween20, supplemented with Roche Protease Inhibitor
Cocktail; 100 mL per 1 L of culture). Cells were lysed for 30 min
by sonication (20% amplitude, 3 sec pulse on, 17 sec pulse off,
4°C) and lysates were clarified at 18,000g for 30 min at 4°C.
HASt-MmDHX37ΔCTD was purified by Strep-Tactin affinity chro-
matography using 2 mL of Strep-Tactin resin (Strep-Tactin
Superflow; IBA). The bound protein was washed with lysis buffer
(20 mM Tris pH 7.5, 350 mM KCl, 1 mM DTT, 0.05% Tween20)
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and eluted with lysis buffer supplemented with 2.5 mM
desthiobiotin.
DHX37 overexpression experiments
HeLa FlpIn TREx cells (kind gift from Dr. M. Beck, EMBL,
Heidelberg) were grown in DMEM containing 10% fetal bovine
serum supplemented with penicillin/streptomycin at 37°C and
5% CO2. Monoclonal HeLa cell lines expressing amino-terminally
EGFP-tagged WT, ΔCTD and E369Q MmDHX37 proteins were
generated by stable integration of the plasmid DNA constructs
into the FRT site. All cell lines were tested negative for mycoplas-
ma using PCR-based testing. Expression of the constructs was in-
duced by the addition of tetracycline for 24 h (WT: 5.6 ng/mL,
ΔCTD: 500 ng/mL, E369Q: 16.7 ng/mL).
CRISPRi knockdown-rescue experiments
For CRISPRi-mediated DHX37 depletion, we modified the meth-
od originally described by the Weissman laboratory (Gilbert et al.
2014) by adding an additional nuclear localization signal to the
catalytically inactive Cas9D10A, H840A mutant (dCas9). In brief,
KRAB-dCas9 was amplified from pHR-SFFV-KRAB-dCas9-P2A-
mCherry (kind gift of Dr. J. Weissman; Addgene, #60954). The re-
sulting PCR product KRAB-dCas9-HA-2xSV40-NLS was cloned
into the AgeI/XhoI sites of the pC2P vector (kind gift of
Dr. M. Bühler; Friedrich Miescher Institute for Biomedical
Research, Basel) containing a puromycin resistance cassette sep-
arated by a self-cleaving P2A (porcine teschovirus-1 2A) site from
the upstream dCas9 fusion protein. Subsequently, the coding se-
quence for the importin-β binding (IBB) domain of importin α
(RCH1) was inserted into the AgeI/HindIII-digested vector at the
5′ end of the dCAS9 cassette. A guide RNA targeting the
DHX37 gene was inserted into the BsaI-sites of the same vector
by primer annealing (5′-caacgGGTGGTCTGGGAACCCACGT-3′
and 5′-aaacACGTGGGTTCCCAGACCACCc), allowing sgRNA
expression from a U6 promoter. An analogous vector containing
a gRNA targeting the Danio rerio tia1l served as control (Lackner
et al. 2015; 5′-caccgGGTATGTCGGGAACCTCTCC-3′ and 5′-
aaacGGAGAGGTTCCCGACATACCc). For CRISPRi rescue exper-
iments, HeLa cell lines were transfected with CRISPRi vectors us-
ing the X-tremeGENE 9 transfection reagent (Roche). After 24 h,
cells were reseeded and selected for successful transfection by
treatment with 2 μg/mL puromycin for 24 h. Puromycin was
washed out thoroughly with PBS and expression of the EGFP-
MmDHX37 constructs was induced for 24 h. Ninety minutes be-
fore fixation, cells were treated with 20 nM leptomycin B (LMB,
LC Laboratories) or solvent (ethanol).
Immunoblot and immunofluorescence analysis
and confocal microscopy
For protein analysis, whole cell extracts were prepared by lysis of
cells in SDS sample buffer. Samples were analyzed by SDS-PAGE
followed by wet-blotting onto PVDF membranes. Signals were
detected on an Odyssey imaging system (LI-COR). The anti-
ENP1 antibody has been described previously (Zemp et al.
2009). Commercial antibodies were anti-β-actin (A1987, Sigma)
and anti-DHX37 (ab70778, abcam). Immunofluorescence analysis
was performed as described previously (Zemp et al. 2009).
Images were acquired at a Zeiss LSM 880 upright microscope
with a 63× 1.4 NA, oil, DIC Plan-Apochromat objective.
DATA DEPOSITION
Coordinates and structure factors of the MmDHX37–RNA com-
plex structure have been deposited in the Protein Data Bank
with the entry code 6O16.
SUPPLEMENTAL MATERIAL
Supplemental material is available for this article.
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